11 insiders have filed at MEDP since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.
| name | role | reported stake | % of company | buys (3y) | sells (3y) |
|---|---|---|---|---|---|
| Troendle August J. | CEO | 5.38M | 18.573% | 66 sells $785.1M | |
| Medpace Investors, Llc | 10% owner | 4.73M | 16.342% | 32 sells $516.4M | |
| Burwig Susan E | Exec. VP, Operations | 70.5k | 0.243% | 9 sells $39.4M | |
| Carley Brian T | Director | 32.8k | 0.113% | 1 sells $1.4M | |
| Ewald Stephen P | General Counsel & Corp. Secy. | 16.8k | 0.058% | 1 buys $1k | 5 sells $16.6M |
| Geiger Jesse J | President | 15.0k | 0.052% | 7 sells $70.1M | |
| Mccarthy Cornelius P. III | Director | 10.3k | 0.036% | 1 sells $773k | |
| Brady Kevin M. | CFO & Treasurer | 5.8k | 0.02% | 3 sells $9.0M | |
| Davenport Fred B JR | Director | 5.5k | 0.019% | 2 sells $4.0M | |
| Kraft Robert O. | Director | 889 | <0.01% | 4 sells $10.7M | |
| Keating Ashley M. | Director | 250 | <0.01% | 5 sells $703k |
Full register at boothcheck.com/insiders/MEDP. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.